Xoma licenses out its bacterial expression systems

XOMA granted non-exclusive licenses for its bacterial cell expression system to Celltech (LSE:CCH) and ZymoGenetics (Seattle, Wash.), a subsidiary of Novo Nordisk. The CCH license is a cross-license g...